Abdallah Raafat Mohyeldeen Abdelrahman, Elshafei Ahmed Mohamed Kamal, AttaAllah Heba Radi
Ophthalmology Department, Minia University, El-Minia, Egypt.
Ophthalmology Department, Minia University Hospital, El-Minia, Egypt.
Eye Vis (Lond). 2021 Oct 3;8(1):36. doi: 10.1186/s40662-021-00259-x.
Evaluation of the patency and position of perforated lacrimal punctal plugs implanted for treating punctal stenosis together with quantitative assessment of the precorneal tear film using anterior segment optical coherence tomography (AS-OCT).
In a prospective study, the lower punctum of 54 eyes of 29 patients implanted with perforated punctal plugs were examined using AS-OCT during the early postoperative period. Preoperative tear meniscus height (TMH) and tear meniscus area (TMA) were evaluated. Postoperatively, the patency of the plug, its position, TMH and TMA were evaluated, and the results were correlated with postoperative epiphora. Munk scale was used for epiphora grading.
Using AS-OCT, 48 (88.9%) plugs were found in proper position while 6 (11.1%) were rotated. The lumen of the plugs was completely patent in 47 (87%) plugs, partially obstructed in 2 (3.7%) plugs and completely occluded in 5 (9.2%) plugs. There was a statistically significant postoperative decrease of TMH and TMA (P < 0.001) and postoperative epiphora Munk score (P < 0.001).
AS-OCT is a valuable, reliable, and noninvasive investigative tool that can detect the proper positioning, patency, and contents of the implanted perforated lacrimal punctal plugs in addition to measurement of TMH and TMA. Trial registration ClinicalTrials.gov ID: NCT04624022, https://clinicaltrials.gov/ct2/show/NCT04624022.
评估用于治疗泪点狭窄的穿孔泪点塞的通畅情况和位置,并使用眼前节光学相干断层扫描(AS-OCT)对角膜前泪膜进行定量评估。
在一项前瞻性研究中,对29例患者的54只眼植入穿孔泪点塞后,在术后早期使用AS-OCT检查下泪点。评估术前泪液半月皱襞高度(TMH)和泪液半月皱襞面积(TMA)。术后,评估泪点塞的通畅情况、位置、TMH和TMA,并将结果与术后溢泪情况相关联。采用蒙克量表进行溢泪分级。
使用AS-OCT发现,48个(88.9%)泪点塞位置合适,6个(11.1%)发生旋转。47个(87%)泪点塞的管腔完全通畅,2个(3.7%)部分阻塞,5个(9.2%)完全闭塞。术后TMH、TMA和术后溢泪蒙克评分均有统计学意义的下降(P < 0.001)。
AS-OCT是一种有价值、可靠且无创的检查工具,除了测量TMH和TMA外,还能检测植入的穿孔泪点塞的正确位置、通畅情况及内容物。试验注册ClinicalTrials.gov标识符:NCT04624022,https://clinicaltrials.gov/ct2/show/NCT04624022。